SCHEMBL4482487

SCHEMBL4482487

Nc1ccc2cc(S(=O)(=O)NCc3ccccc3)ccc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.67
PKM P14618 2/20 0.60
KEAP1 Q14145 1/20 0.58
IDO1 P14902 1/20 0.58
LMNA P02545 1/20 0.57
SLC12A2 P55011 1/20 0.57
SLC12A5 Q9H2X9 1/20 0.57
F2 P00734 1/20 0.56
CA12 O43570 3/20 0.55
CA9 Q16790 3/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 3/20 0.55
POLB P06746 2/20 0.55
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4486932 0.99 CYP19A1 (0.65) CYP19A1PKMKEAP1IDO1LMNA
SCHEMBL3681880 0.88 CYP19A1 (0.85) CYP19A1PKMKEAP1IDO1LMNA
SCHEMBL38660104 0.88 CYP19A1 (0.85) CYP19A1PKMKEAP1IDO1LMNA
SCHEMBL151655 0.84 KEAP1 (0.76) CYP19A1KEAP1LMNASLC12A2SLC12A5
SCHEMBL5032445 0.83 CYP19A1 (0.85) CYP19A1PKMKEAP1LMNASLC12A2
SCHEMBL31339948 0.83 CYP19A1 (0.85) CYP19A1PKMKEAP1LMNASLC12A2
SCHEMBL4481323 0.82 HDAC3 (0.55) CYP19A1CA12CA9CYP1A2CYP3A4
SCHEMBL5952598 0.80 KEAP1 (0.64) CYP19A1PKMKEAP1LMNASLC12A2
SCHEMBL2492471 0.80 KEAP1 (0.69) CYP19A1KEAP1LMNASLC12A2SLC12A5
SCHEMBL4470901 0.79 CYP19A1 (0.62) CYP19A1PKMKEAP1IDO1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050215645-A1 Amide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2005-09-29 US claimed
US-7598418-B2 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-10-06 US disclosed
US-20050215645-A1 Amide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215645-A1 Amide derivatives OGG1, HDAC1, BCL2A1 CYP19A1 552/4885PKM 2153/4885KEAP1 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.